Escherichia coli sequence type 131 (ST131) is an important global health issue nowadays and is responsible for many clinical infections. Here, we present the complete genome sequences of two ST131 clinical isolates and one ST131 fecal isolate.
ABSTRACT
Escherichia coli sequence type 131 (ST131) is an important global health issue nowadays and is responsible for many clinical infections. Here, we present the complete genome sequences of two ST131 clinical isolates and one ST131 fecal isolate.
ANNOUNCEMENT
Escherichia coli sequence type 131 (ST131) has recently emerged as an extensively antimicrobial-resistant E. coli clonal group throughout the world and is driving a rapid increase in the spread of antimicrobial resistance in E. coli (1, 2). This clonal group is an epidemiologically important clone among the extended-spectrum beta-lactamase (ESBL)-producing E. coli strains and frequently shows high resistance to fluoroquinolones (1, 2). ST131 is a highly successful E. coli clone, as strains of this clone can cause a wide variety of clinical infections. Previous studies showed that human gut flora is a possible reservoir of E. coli ST131 strains (3, 4). We describe here the complete genome sequences of three E. coli ST131 strains, including one isolated from a fecal sample from a healthy volunteer.
Three E. coli ST131 strains were isolated in 2016 as part of a screening program for gut E. coli ST131 colonization status among healthy persons and for E. coli ST131 infection in patients in a large teaching hospital in China (5). These isolates belonged to serotype O25, as described previously (5). Strains were grown on Columbia blood agar prior to sequencing. The genomic DNA samples were extracted from these three isolates using a DNeasy blood and tissue kit (Qiagen, Germany), according to the manufacturer’s protocols, sequenced on an Illumina HiSeq 4000 sequencer using paired-end 2 × 150-bp reads with approximately 200× coverage, and assembled de novo using MicrobeTraker Plus version 0.9.1, with default settings. Read quality was examined using FastQC version 0.11.5. The total numbers of reads of three isolates (EC191, EC192, and EC193) are 5,575,934 bp, 609,608 bp, and 6,033,888 bp, respectively. The read length is 150 bp. The number of contigs and N50 size of the three E. coli strains (EC191, EC192, and EC193) are as follows: 41 and 343,410 bp, 81 and 401,068 bp, and 111 and 159,190 bp, respectively. The genomes were annotated using NCBI’s Prokaryotic Genome Annotation Pipeline version 4.2 (6). The accession numbers and assembly metrics are listed in Table 1.
TABLE 1.
Accession numbers and assembly metrics of three draft whole-genome sequences for E. coli ST131 O25 strains
| Isolate | GenBank accession no. | Genome size (bp) | G+C content (%) | SRA accession no. |
|---|---|---|---|---|
| EC191 | PCFN00000000 | 5,043,855 | 50.7 | SRR8203406 |
| EC192 | PCFO00000000 | 5,057,410 | 50.6 | SRR8203407 |
| EC193 | PCFP00000000 | 5,266,412 | 50.7 | SRR8203405 |
Data availability.
The complete genome sequences of the three E. coli ST131 isolates reported here have been deposited in GenBank under the accession numbers PCFN00000000, PCFO00000000, and PCFP00000000. The BioProject number is PRJNA407669.
ACKNOWLEDGMENT
This work was supported by the Joint Funds for the Innovation of Science and Technology, Fujian Province, China (grant 2017Y9049).
REFERENCES
- 1.Mathers AJ, Peirano G, Pitout JD. 2015. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 28:565–591. doi: 10.1128/CMR.00116-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dautzenberg MJ, Haverkate MR, Bonten MJ, Bootsma MC. 2016. Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis. BMJ Open 6:e009971. doi: 10.1136/bmjopen-2015-009971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM. 2015. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China. J Antimicrob Chemother 70:2223–2227. doi: 10.1093/jac/dkv114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D. 2017. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: comparison of genomic and phenotypic traits with those of the globally successful H30 subclone. BMC Microbiol 17:71. doi: 10.1186/s12866-017-0984-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li B, Lu Y, Lan F, He Q, Li C, Cao Y. 2017. Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital. Antimicrob Resist Infect Control 6:118. doi: 10.1186/s13756-017-0274-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L, Lomsadze A, Pruitt KD, Borodovsky M, Ostell J. 2016. NCBI Prokaryotic Genome Annotation Pipeline. Nucleic Acids Res 44:6614–6624. doi: 10.1093/nar/gkw569. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The complete genome sequences of the three E. coli ST131 isolates reported here have been deposited in GenBank under the accession numbers PCFN00000000, PCFO00000000, and PCFP00000000. The BioProject number is PRJNA407669.
